Magle Chemoswed Holding AB (publ) (STO:MAGLE)
Sweden · Delayed Price · Currency is SEK 1.000
-0.030 (-2.91%)
Jun 18, 2026, 4:53 PM CET
STO:MAGLE Market Cap
STO:MAGLE has a market cap or net worth of 28.2 million as of June 18, 2026. Its market cap has decreased by -94.71% in one year.
Market Cap
28.20M
Enterprise Value
384.35M
Revenue
273.25M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.00
Market Cap Chart
Since June 30, 2020, STO:MAGLE's market cap has decreased from 205.10M to 28.20M, a decrease of -86.25%. That is a compound annual growth rate of -28.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 28.20M | -92.24% |
| Dec 30, 2025 | 363.43M | -43.25% |
| Dec 30, 2024 | 640.39M | 135.30% |
| Dec 29, 2023 | 272.16M | -5.97% |
| Dec 30, 2022 | 289.44M | -10.37% |
| Dec 30, 2021 | 322.92M | -29.72% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Annexin Pharmaceuticals AB | 85.77M |
| Spago Nanomedical AB | 77.73M |
| Alzinova AB | 74.30M |
| Pila Pharma AB | 63.27M |
| 2cureX AB | 60.93M |
| Modus Therapeutics Holding AB | 49.14M |
| Fluicell AB | 47.67M |
| Guard Therapeutics International AB | 31.30M |